Improving recruitment, efficiency and quality of academic cancer clinical trials in Canada
Access
- Bringing high-quality trial options to underserved communities by engaging local care providers and enabling decentralized trial delivery
Outcomes
- Efficient delivery of cancer clinical trials
- 40,000+ patients recruited to academic cancer clinical trials (ACCTs)
Impact
- 850+ ACCTS
- 400+ trial publications
- 70+ practice changing trials
Network Tools & Resources
3CTN Reports
News & Events
-
EDGE Essentials June 2026
This edition highlights Smarter Financial Tracking with EDGE, so teams can manage high-level project costs, site set-up fees, and participant-level procedure costs within a single structure. You’ll also find training resources and drop-in support, our Tip of the Month on how to utilize EDGE’s built in document management features, and answers to a common FAQ.
-
New funding to bring cutting-edge cancer clinical trials closer to home for Canadians
The Canadian Cancer Clinical Trials Network, its member cancer centres, and partners continue their work to eliminate barriers to clinical trial access for Canadians with cancer. June 3, 2026 (Toronto) – The Canadian Cancer Clinical Trials Network (3CTN) today announced funding for six new projects that aim to overcome barriers that can make trial participation difficult…
-
impACCT Virtual Rounds Spring Session 2026
Date: Tuesday, June 9, 2026 Time: 12:00 p.m. – 1:00 p.m. EDT Location: Virtual Event Facilitator: Carol Hill, Chair of Patient Representative Advisory Sub-Committee Session #1 Trial #1: (BCC) CHRONO-RCC – Time-of-day–dependent administration of dual immune check point inhibitors (ICI) in advanced kidney cancer (NCT07338981) Trial #2: (BCC) CHRONO-EVP – Time-of-day dependent administration of…
Our Partners
Our Canada-wide initiative is made possible by contributions from our funders and through collaborations with organizations who share our vision for the cancer clinical trial landscape.
Funding Partners
Collaborators
